Considerations On Cost Disease

I. Tyler Cowen writes about cost disease. I’d previously heard the term used to refer only to a specific theory of why costs are increasing, involving labor becoming more efficient in some ar…

Annals of Int Med on X: A #CostEffectiveness analysis of #GeneTherapy for #SCD found that while gene therapy is cost ineffective, it can be an equitable therapeutic strategy for people living w/

Health Care Payers COVID-19 Impact Assessment: Lessons Learned and Compelling Needs - National Academy of Medicine

Special Considerations For Qualifying For SSDI With A Rare Disease

Clinical Trial Considerations in Developing Treatments for Early Stages of Common, Chronic Kidney Diseases: A Scientific Workshop Cosponsored by the National Kidney Foundation and the US Food and Drug Administration - ScienceDirect

Self-care interventions for advancing sexual and reproductive health and rights – implementation considerations

Managed Care Considerations in the Use of JAK Inhibitors in Myelofibrosis

Making the Business Case for CDC's 6, 18 Initiative Interventions: Key Considerations - Implementing CDC's 6

George Goshua, MD MSc on X: 🚨@AnnalsofIM embargo lift on @YaleMed - @HarvardHPM collaboration: Quantification of health equity weight thresholds w/ DCEA of gene therapy vs standard-of-care in sickle cell disease @cececalhounMD @

Solved There are distinct differences between managing an

Considerations On Cost Disease